BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 30969503)

  • 1. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
    Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
    N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab.
    Rauer S; Marks R; Urbach H; Warnatz K; Nath A; Holland S; Weiller C; Grimbacher B
    N Engl J Med; 2019 Apr; 380(17):1676-1677. PubMed ID: 30969507
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab.
    Walter O; Treiner E; Bonneville F; Mengelle C; Vergez F; Lerebours F; Delobel P; Liblau R; Martin-Blondel G;
    N Engl J Med; 2019 Apr; 380(17):1674-1676. PubMed ID: 30969500
    [No Abstract]   [Full Text] [Related]  

  • 4. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
    Holmes A; Wellings T; Walsh O; Rowlings P
    J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.
    Aly L; Yousef S; Schippling S; Jelcic I; Breiden P; Matschke J; Schulz R; Bofill-Mas S; Jones L; Demina V; Linnebank M; Ogg G; Girones R; Weber T; Sospedra M; Martin R
    Brain; 2011 Sep; 134(Pt 9):2687-702. PubMed ID: 21908874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab.
    Varmpompiti K; Westwood AJ; Ben-Joseph A; Sibtain N; Ibrahim MAA; Stanton B; Zuckerman M; Hadden R; Ritter LM
    J Neuroimmunol; 2023 Dec; 385():578248. PubMed ID: 37995595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in People Living with HIV.
    Pinnetti C; Cimini E; Vergori A; Mazzotta V; Grassi G; Mondi A; Forbici F; Amendola A; Grisetti S; Baldini F; Candela C; Casetti R; Campioni P; Capobianchi MR; Agrati C; Antinori A
    Viruses; 2022 May; 14(5):. PubMed ID: 35632711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy treated with nivolumab.
    Hoang E; Bartlett NL; Goyal MS; Schmidt RE; Clifford DB
    J Neurovirol; 2019 Apr; 25(2):284-287. PubMed ID: 30864100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control.
    Schwab N; Ulzheimer JC; Fox RJ; Schneider-Hohendorf T; Kieseier BC; Monoranu CM; Staugaitis SM; Welch W; Jilek S; Du Pasquier RA; Brück W; Toyka KV; Ransohoff RM; Wiendl H
    Neurology; 2012 Feb; 78(7):458-67; discussion 465. PubMed ID: 22302546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
    Wijburg MT; Kleerekooper I; Lissenberg-Witte BI; de Vos M; Warnke C; Uitdehaag BMJ; Barkhof F; Killestein J; Wattjes MP
    JAMA Neurol; 2018 Jul; 75(7):827-833. PubMed ID: 29532061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy.
    Sanjo N; Nose Y; Shishido-Hara Y; Mizutani S; Sekijima Y; Aizawa H; Tanizawa T; Yokota T
    J Neurol; 2019 Feb; 266(2):369-377. PubMed ID: 30511098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review.
    Lan TY; Chen YS; Cheng CF; Huang ST; Shen CY; Hsu PN
    Lupus; 2021 Oct; 30(11):1849-1855. PubMed ID: 34325541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
    Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy.
    Tan CS; Bord E; Broge TA; Glotzbecker B; Mills H; Gheuens S; Rosenblatt J; Avigan D; Koralnik IJ
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):244-8. PubMed ID: 22549384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy.
    Vendrely A; Bienvenu B; Gasnault J; Thiebault JB; Salmon D; Gray F
    Acta Neuropathol; 2005 Apr; 109(4):449-55. PubMed ID: 15739098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
    Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
    BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].
    Takase K; Ohyagi Y; Furuya H; Nagashima K; Taniwaki T; Kira J
    Rinsho Shinkeigaku; 2005 Jun; 45(6):426-30. PubMed ID: 16022467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JC virus quasispecies analysis reveals a complex viral population underlying progressive multifocal leukoencephalopathy and supports viral dissemination via the hematogenous route.
    Van Loy T; Thys K; Ryschkewitsch C; Lagatie O; Monaco MC; Major EO; Tritsmans L; Stuyver LJ
    J Virol; 2015 Jan; 89(2):1340-7. PubMed ID: 25392214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy.
    Beck ES; Cortese I
    Curr Opin Virol; 2020 Feb; 40():19-27. PubMed ID: 32279025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.
    Muftuoglu M; Olson A; Marin D; Ahmed S; Mulanovich V; Tummala S; Chi TL; Ferrajoli A; Kaur I; Li L; Champlin R; Shpall EJ; Rezvani K
    N Engl J Med; 2018 Oct; 379(15):1443-1451. PubMed ID: 30304652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.